Rallybio
0 followers
RLYB
Performance
About Rallybio
Rallybio is a biotechnology company focused on developing therapies for rare diseases, aiming to change outcomes for patients with complement dysregulation and related hematology conditions. Its pipeline includes assets such as C5 inhibitors with potential best-in-class profiles, and the company emphasizes translational science to convert scientific breakthroughs into life-changing treatments for patients living with rare diseases. Based in New Haven, Connecticut, Rallybio highlights a mission to advance unimagined therapies and better patient outcomes beyond headline-generating results.
Recent News
No recent news for this company.